Lotus Pharmaceutical Co., Ltd. announced audit and remuneration committee changes. Name and resume of the previous position holder: Audit Committee: Hjorleifur Palsson /Independent Director at Lotus Pharmaceutical Co., Ltd.; Karl Alexius Tiger Karlsson /Independent Director at Lotus Pharmaceutical Co., Ltd. and Jennifer Wang /Independent Director at Lotus Pharmaceutical Co., Ltd. Remuneration Committee: Hjorleifur Palsson /Independent Director at Lotus Pharmaceutical Co., Ltd.; Karl Alexius Tiger Karlsson /Independent Director at Lotus Pharmaceutical Co., Ltd. and Jennifer Wang /Independent Director at Lotus Pharmaceutical Co., Ltd. Name and resume of the new position holder: Audit Committee: Jennifer Wang /Independent Director at Lotus Pharmaceutical Co., Ltd.; Ivy Yang /Chief Financial Officer of DBS Bank (Taiwan) Ltd. and Karl Alexius Tiger Karlsson /Independent Director at Lotus Pharmaceutical Co., Ltd. Remuneration Committee: Jennifer Wang /Independent Director at Lotus Pharmaceutical Co., Ltd.; Ivy Yang /Chief Financial Officer of DBS Bank (Taiwan) Ltd. and Karl Alexius Tiger Karlsson /Independent Director at Lotus Pharmaceutical Co., Ltd. Effective date of the new member is June 13, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
306.5 TWD | +0.99% |
|
+0.49% | +12.68% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.68% | 2.48B | |
+56.50% | 809B | |
+39.52% | 624B | |
-7.23% | 351B | |
+7.11% | 289B | |
+13.74% | 240B | |
+13.83% | 220B | |
-0.49% | 219B | |
+8.31% | 166B | |
-3.02% | 157B |
- Stock Market
- Equities
- 1795 Stock
- News Lotus Pharmaceutical Co., Ltd.
- Lotus Pharmaceutical Co., Ltd. Announces Audit and Remuneration Committee Changes